Literature DB >> 25214197

Cellular therapy of the host to prevent GVHD.

James Ferrara1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25214197      PMCID： PMC4162103          DOI： 10.1182/blood-2014-07-590380

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  Induction of acute GVHD by sex-mismatched H-Y antigens in the absence of functional radiosensitive host hematopoietic-derived antigen-presenting cells.

Authors:  Tomomi Toubai; Isao Tawara; Yaping Sun; Chen Liu; Evelyn Nieves; Rebecca Evers; Thea Friedman; Robert Korngold; Pavan Reddy
Journal:  Blood       Date:  2011-11-18       Impact factor: 22.113

2.  Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease.

Authors:  Motoko Koyama; Rachel D Kuns; Stuart D Olver; Neil C Raffelt; Yana A Wilson; Alistair L J Don; Katie E Lineburg; Melody Cheong; Renee J Robb; Kate A Markey; Antiopi Varelias; Bernard Malissen; Günter J Hämmerling; Andrew D Clouston; Christian R Engwerda; Purnima Bhat; Kelli P A MacDonald; Geoffrey R Hill
Journal:  Nat Med       Date:  2011-11-29       Impact factor: 53.440

3.  Prevention of graft versus host disease by inactivation of host antigen-presenting cells.

Authors:  W D Shlomchik; M S Couzens; C B Tang; J McNiff; M E Robert; J Liu; M J Shlomchik; S G Emerson
Journal:  Science       Date:  1999-07-16       Impact factor: 47.728

4.  Cutaneous T cell lymphoma and graft-versus-host disease: a comparison of in vivo effects of extracorporeal photochemotherapy on Foxp3+ regulatory T cells.

Authors:  Vidar Rao; Marit Saunes; Størker Jørstad; Torolf Moen
Journal:  Clin Immunol       Date:  2009-09-20       Impact factor: 3.969

5.  Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host models.

Authors:  Mareike Florek; Emanuela I Sega; Dennis B Leveson-Gower; Jeanette Baker; Antonia M S Müller; Dominik Schneidawind; Everett Meyer; Robert S Negrin
Journal:  Blood       Date:  2014-07-16       Impact factor: 22.113

6.  Donor APCs are required for maximal GVHD but not for GVL.

Authors:  Catherine C Matte; Jinli Liu; James Cormier; Britt E Anderson; Ioanna Athanasiadis; Dhanpat Jain; Jennifer McNiff; Warren D Shlomchik
Journal:  Nat Med       Date:  2004-08-01       Impact factor: 53.440

7.  Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells.

Authors:  Erin Gatza; Clare E Rogers; Shawn G Clouthier; Kathleen P Lowler; Isao Tawara; Chen Liu; Pavan Reddy; James L M Ferrara
Journal:  Blood       Date:  2008-04-14       Impact factor: 22.113

8.  Single infusion of donor mononuclear early apoptotic cells as prophylaxis for graft-versus-host disease in myeloablative HLA-matched allogeneic bone marrow transplantation: a phase I/IIa clinical trial.

Authors:  Dror Mevorach; Tsila Zuckerman; Inna Reiner; Avichai Shimoni; Simcha Samuel; Arnon Nagler; Jacob M Rowe; Reuven Or
Journal:  Biol Blood Marrow Transplant       Date:  2013-10-15       Impact factor: 5.742

9.  Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.

Authors:  Ettore Biagi; Iolanda Di Biaso; Veronica Leoni; Giuseppe Gaipa; Vincenzo Rossi; Cristina Bugarin; Giuliano Renoldi; Matteo Parma; Adriana Balduzzi; Paolo Perseghin; Andrea Biondi
Journal:  Transplantation       Date:  2007-07-15       Impact factor: 4.939
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.